FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q57821629> ?p ?o ?g. }

• Q57821629 description "2018 nî lūn-bûn" @default.
• Q57821629 description "2018年の論文" @default.
• Q57821629 description "2018年学术文章" @default.
• Q57821629 description "2018年学术文章" @default.
• Q57821629 description "2018年学术文章" @default.
• Q57821629 description "2018年学术文章" @default.
• Q57821629 description "2018年学术文章" @default.
• Q57821629 description "2018年學術文章" @default.
• Q57821629 description "2018年學術文章" @default.
• Q57821629 description "2018年學術文章" @default.
• Q57821629 description "2018年學術文章" @default.
• Q57821629 description "2018年學術文章" @default.
• Q57821629 description "2018年學術文章" @default.
• Q57821629 description "2018년 논문" @default.
• Q57821629 description "article científic" @default.
• Q57821629 description "article scientific" @default.
• Q57821629 description "article scientifique publié en 2018" @default.
• Q57821629 description "articol științific" @default.
• Q57821629 description "articolo scientifico" @default.
• Q57821629 description "artigo científico (publicado na 2018)" @default.
• Q57821629 description "artigo científico (publicado na 2018)" @default.
• Q57821629 description "artigo científico" @default.
• Q57821629 description "artikull shkencor" @default.
• Q57821629 description "artikulong pang-agham" @default.
• Q57821629 description "artykuł naukowy" @default.
• Q57821629 description "artículo científico publicado en 2018" @default.
• Q57821629 description "artículu científicu espublizáu en setiembre de 2018" @default.
• Q57821629 description "bilimsel makale" @default.
• Q57821629 description "bài báo khoa học" @default.
• Q57821629 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
• Q57821629 description "mokslinis straipsnis" @default.
• Q57821629 description "naučni članak" @default.
• Q57821629 description "scienca artikolo" @default.
• Q57821629 description "scientific article published on 24 September 2018" @default.
• Q57821629 description "teaduslik artikkel" @default.
• Q57821629 description "tieteellinen artikkeli" @default.
• Q57821629 description "tudományos cikk" @default.
• Q57821629 description "vedecký článok" @default.
• Q57821629 description "vetenskaplig artikel" @default.
• Q57821629 description "videnskabelig artikel (udgivet 2018)" @default.
• Q57821629 description "vitenskapelig artikkel" @default.
• Q57821629 description "vitskapeleg artikkel" @default.
• Q57821629 description "vědecký článek" @default.
• Q57821629 description "wetenschappelijk artikel" @default.
• Q57821629 description "επιστημονικό άρθρο" @default.
• Q57821629 description "мақолаи илмӣ" @default.
• Q57821629 description "мақолаи илмӣ" @default.
• Q57821629 description "наукова стаття, опублікована у вересні 2018" @default.
• Q57821629 description "научна статия" @default.
• Q57821629 description "научная статья" @default.
• Q57821629 description "научни чланак" @default.
• Q57821629 description "научни чланак" @default.
• Q57821629 description "գիտական հոդված" @default.
• Q57821629 description "מאמר מדעי" @default.
• Q57821629 description "سائنسی مضمون" @default.
• Q57821629 description "مقالة علمية" @default.
• Q57821629 description "مقالهٔ علمی" @default.
• Q57821629 description "২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q57821629 description "บทความทางวิทยาศาสตร์" @default.
• Q57821629 description "სამეცნიერო სტატია" @default.
• Q57821629 name "Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)" @default.
• Q57821629 name "Local Consolidation Therapy" @default.
• Q57821629 type Item @default.
• Q57821629 label "Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)" @default.
• Q57821629 label "Local Consolidation Therapy" @default.
• Q57821629 prefLabel "Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)" @default.
• Q57821629 prefLabel "Local Consolidation Therapy" @default.
• Q57821629 P1433 Q57821629-9FDCAADF-6E8D-4E63-8063-00DB1D7B9EC5 @default.
• Q57821629 P1476 Q57821629-3394FB26-EBA6-45CF-9CF5-420A3CBA7EDA @default.
• Q57821629 P2093 Q57821629-01910E61-7F28-4DF7-890A-E9B2F20DBC07 @default.
• Q57821629 P2093 Q57821629-0473A1C2-30EF-4671-A62D-4BA0AA51CA77 @default.
• Q57821629 P2093 Q57821629-1A2BC1F0-E7E2-432D-9C26-6A32AD4E48D9 @default.
• Q57821629 P2093 Q57821629-1B0E3665-E19F-43EF-A2F2-172E99B87F97 @default.
• Q57821629 P2093 Q57821629-2484F98B-F334-40CE-908B-D7ED6D214E4C @default.
• Q57821629 P2093 Q57821629-26DED87E-144F-4C7D-88C7-E0833B5BB7E1 @default.
• Q57821629 P2093 Q57821629-3EE6EC8C-EC29-4995-98C4-0176FD6BE741 @default.
• Q57821629 P2093 Q57821629-3F0A617A-372A-4393-ADB0-B1BD38A643DE @default.
• Q57821629 P2093 Q57821629-4445AABF-EF67-4DA9-B83E-349282272709 @default.
• Q57821629 P2093 Q57821629-582987AF-2E36-4B6D-9591-4025E486BBC2 @default.
• Q57821629 P2093 Q57821629-63CD24FA-62E9-4611-92DF-FE1E3BCC4821 @default.
• Q57821629 P2093 Q57821629-A281A828-3C50-4AE8-A900-2EE1212D270A @default.
• Q57821629 P2093 Q57821629-AD754520-8479-4F1D-88BE-BD616158AD51 @default.
• Q57821629 P304 Q57821629-CBCD6B1E-F558-42C2-B15A-D2A5CA21F723 @default.
• Q57821629 P31 Q57821629-8504705B-CCCE-46EF-B069-1963063B8C40 @default.
• Q57821629 P356 Q57821629-5DBA2378-A5D1-4354-80BD-A643E2B1D621 @default.
• Q57821629 P407 Q57821629-BD0A9861-0ECA-4D39-A040-8A75D242DCBA @default.
• Q57821629 P433 Q57821629-37C781C8-3D2F-4EF4-B421-731B754022F0 @default.
• Q57821629 P478 Q57821629-00945058-DC1F-4809-A1D7-2D3F115CC76D @default.
• Q57821629 P50 Q57821629-46723914-6289-45C3-A852-485CFAAA780F @default.
• Q57821629 P50 Q57821629-82EC7A8C-31B7-4B9B-97CE-EB824CC58037 @default.
• Q57821629 P50 Q57821629-9CFA0CC6-88B4-493B-A77A-AE15A4628372 @default.
• Q57821629 P50 Q57821629-DEBB243F-5C1D-445D-8C80-EB65C1351231 @default.
• Q57821629 P50 Q57821629-E54ABB8D-D0A8-4412-BA87-DAE4F4CBD7EA @default.
• Q57821629 P577 Q57821629-E810CCE3-A9E5-4C10-BCC7-280DCF51B475 @default.
• Q57821629 P698 Q57821629-CCEFFDA9-4044-4E86-B96F-26A519600C9F @default.
• Q57821629 P356 J.CLLC.2018.09.015 @default.
• Q57821629 P698 30343004 @default.
• Q57821629 P1433 Q332299 @default.
• Q57821629 P1476 "Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)" @default.
• Q57821629 P2093 "Daniel R Gomez" @default.

• next